Skip to Content

Sufentanil Injection

Last Updated: November 27, 2018
Status: Current

Products Affected - Description
    • Sufenta solution for injection, Akorn, 50 mcg/mL, 1 mL ampule, 10 count, NDC 17478-0050-01
    • Sufenta solution for injection, Akorn, 50 mcg/mL, 2 mL ampule, 10 count, NDC 17478-0050-02
    • Sufenta solution for injection, Akorn, 50 mcg/mL, 5 mL ampule, 10 count, NDC 17478-0050-05
Reason for the Shortage
    • Akorn has Sufenta injection on shortage due to increased demand for the product.
    • Hikma stopped marketing sufentanil injection in October 2018.
    • Pfizer has sufentanil injection on shortage due to manufacturing delays.
Available Products
    • Sufentanil solution for injection, Pfizer, 50 mcg/mL, 1 mL vial, 10 count, NDC 00409-3382-21
    • Sufentanil solution for injection, Pfizer, 50 mcg/mL, 2 mL vial, 10 count, NDC 00409-3382-22
    • Sufentanil solution for injection, Pfizer, 50 mcg/mL, 5 mL vial, 10 count, NDC 00409-3382-25

Estimated Resupply Dates

    • Akorn has Sufenta 50 mcg/mL 1 mL, 2 mL, and 5 mL ampules on allocation.

Implications for Patient Care

    • ASHP has an FAQ on the injectable opioid shortage at https://www.ashp.org/Drug-Shortages/Shortage-Resources/Injectable-Opioid-Shortages-FAQ. This discusses multiple issues including inventory and pharmacy operational strategies.

Updated

Updated November 27, 2018 by Stephen Andrews, PharmD, Drug Information Specialist. Created January 12, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide